ZYUS Life Sciences Corporation (TSXV: ZYUS)

Canada flag Canada · Delayed Price · Currency is CAD
0.830
-0.020 (-2.35%)
Dec 20, 2024, 10:22 AM EST
-8.79%
Market Cap 61.72M
Revenue (ttm) 452.00K
Net Income (ttm) -36.55M
Shares Out 74.36M
EPS (ttm) -0.52
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Open 0.830
Previous Close 0.850
Day's Range 0.830 - 0.830
52-Week Range 0.700 - 1.190
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date May 8, 2025

About ZYUS Life Sciences

ZYUS Life Sciences Corporation manufactures and distributes cannabinoid-based therapeutics and product candidates in Canada and internationally. The company offers cannabinoid oils, softgel capsules, and topical creams. ZYUS Life Sciences Corporation was founded in 2018 and is based in Saskatoon, Canada. [Read more]

Sector Healthcare
Founded 2018
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol ZYUS
Full Company Profile

Financial Performance

In 2023, ZYUS Life Sciences's revenue was 351,000, an increase of 17.79% compared to the previous year's 298,000. Losses were -42.59 million, 72.7% more than in 2022.

Financial Statements

News

There is no news available yet.